Form D · Biotechnology
SYNLOGIC, INC.
Cambridge, MA · CIK 0001614170
Offering snapshot reported May 26, 2017 · SEC filing
- Reported sold
- $42M Offering amount: $42M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 15, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 26, 2017 | Initial | $42,000,031 | No comparison | 16 | SEC filing |
| Jul 22, 2014 | Initial | $4,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-287588
Source: Form D, filed May 26, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Barrett | Director |
| Aoife Brennan | Executive |
| Lewis Geffen | Executive |
| Daniel Geffken | Executive |
| Jose Carlos Gutierrez Ramos | Director, Executive |
| Chau Khuong | Director |
| Nick Leschly | Director |
| Ankit Mahadevia | Director, Executive |
| Ed Mathers | Director |
| Paul Miller | Executive |
| Todd Shegog | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 Sidney Street, Suite 320
Cambridge, MA, 02139
Cambridge, MA, 02139